Author:
Hansen Richard A.,Gray Michael D.,Fox Brent I.,Hollingsworth Joshua C.,Gao Juan,Zeng Peng
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference14 articles.
1. Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010;153(9):600–6.
2. Observational Medical Outcomes Partnership (2010) [cited 2012 October 8]. http://omop.org/HOI .
3. Ryan PB, Madigan D. Observational Medical Outcomes Partnership (OMOP) methods evaluation. OMOP 2011 Symposium; 2011 January 11; Washington, DC.
4. Racoosin JA, Ryan PB. Implications of health outcomes of interest definitions: acute liver injury case study. OMOP 2011 Symposium; 2011 January 11; Washington, DC.
5. Jinjuvadia K, Kwan W, Fontana RJ. Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury. Am J Gastroenterol. 2007;102(11):2437–43.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献